Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence

Accurate, highly specific immunoassays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are needed to evaluate seroprevalence. This study investigated the concordance of results across four immunoassays targeting different antigens for sera collected at the beginning of the SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Cheryl N., Althoff, Keri N., Schlueter, David J., Anton-Culver, Hoda, Chen, Qingxia, Garbett, Shawn, Ratsimbazafy, Francis, Thomsen, Isaac, Karlson, Elizabeth W., Cicek, Mine, Pinto, Ligia A., Malin, Bradley A., Ohno-Machado, Lucila, Williams, Carolyn, Goldstein, David, Kouame, Aymone, Ramirez, Andrea, Gebo, Kelly A., Schully, Sheri D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599436/
https://www.ncbi.nlm.nih.gov/pubmed/36173112
http://dx.doi.org/10.1128/msphere.00257-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599436/
https://www.ncbi.nlm.nih.gov/pubmed/36173112
http://dx.doi.org/10.1128/msphere.00257-22

Ejemplares similares